Reddy Labs to sell new medicines in USA

Mumbai, MAY 13: Dr.Reddy laboratories has registered a growth of 175 % profit for last quarter of financial year 20176-17.The total revenue earned in the year has stood at RS 14367.6 crores. The company said that its dividend value of the shares has increased by 400 %.The company CEO GV Prakash spoke to Media after the quarterly results were announced. He said that "We will sell new drugs in America in few years".He also said that "We will expand our business into new emerging economies to reduce our losses".He concluded by saying that "the main focus of the company is to rectify some of the problems in our plants which were suggested by USFDA and we will soon reapply for permission ".Market Experts have predicted that loss in revenue of the company is because of the drop in the sale of Global Generic Drugs by 10%.